Mammary tumors in mice conditionally mutant for Brca1 exhibit gross genomic instability and centrosome amplification yet display a recurring distribution of genomic imbalances that is similar to human breast cancer
- 29 July 2002
- journal article
- Published by Springer Nature in Oncogene
- Vol. 21 (33), 5097-5107
- https://doi.org/10.1038/sj.onc.1205636
Abstract
BRCA1 mutation carriers have an increased susceptibility to breast and ovarian cancer. Excision of exon 11 of Brca1 in the mouse, using a conditional knockout (Cre-loxP) approach, results in mammary tumor formation after long latency. To characterize the genomic instability observed in these tumors, to establish a comparative map of chromosomal imbalances and to contribute to the validation of this mouse model of breast cancer, we have characterized chromosomal imbalances and aberrations using comparative genomic hybridization (CGH), and spectral karyotyping (SKY). We found that all tumors exhibit chromosome instability as evidenced by structural chromosomal aberrations and aneuploidy, yet they display a pattern of chromosomal gain and loss that is similar to the pattern in human breast carcinomas. Of note, nine of 15 tumors exhibited a gain of distal chromosome 11, a region that is orthologous to human chromosome 17q11-qter, the mapping position of Erbb2. However, our analysis suggests that genes distal to Erbb2 are the main targets of amplification. Four of the tumors also exhibited a copy number loss of proximal chromosome 11 (11A-B), a region orthologous to human 17p. In eight of the tumors we observed whole or partial gain of chromosome 15 centering on 15D2-D3 (orthologous to human chromosome 8q24), the map location of the c-Myc gene, and six of the tumors exhibited copy number loss of whole or partial chromosome 14, including 14D3, the map location of Rb1. We conclude that despite the tremendous shuffling of chromosomes during the course of mammalian evolution, the pattern of genomic imbalances is conserved between BRCA1-associated mammary gland tumors in mice and humans. Western blot analysis showed that while p53 is absent or mutated in some tumors, at least two tumors revealed wild-type protein, suggesting that other genetic events may lead to tumorigenesis. Similar to BRCA1-deficient mouse embryonic fibroblasts, the tumor cells contained supernumerary functional centrosomes with intact centrioles whose presence results in multipolar mitoses and aneuploidy.Keywords
This publication has 27 references indexed in Scilit:
- Knockout mouse models and mammary tumorigenesisSeminars in Cancer Biology, 2001
- BRCA1 Is Associated with a Human SWI/SNF-Related ComplexCell, 2000
- Role of the tumor suppressor gene Brca1 in genetic stability and mammary gland tumor formationOncogene, 2000
- Specific Chromosomal Aberrations and Amplification of the AIB1 Nuclear Receptor Coactivator Gene in Pancreatic CarcinomasThe American Journal of Pathology, 1999
- Increased copy number at 17q22-q24 by CGH in breast cancer is due to high-level amplification of two separate regionsGenes, Chromosomes and Cancer, 1997
- Inactivation of the mouse Brca1 gene leads to failure in the morphogenesis of the egg cylinder in early postimplantation development.Genes & Development, 1996
- The Tumor Suppressor Gene Brca1 Is Required for Embryonic Cellular Proliferation in the MouseCell, 1996
- Brca1 deficiency results in early embryonic lethality characterized by neuroepithelial abnormalitiesNature Genetics, 1996
- Genetic alterations in breast cancerGenes, Chromosomes and Cancer, 1995
- Thrombopoietin (TPO) induces tyrosine phosphorylation and activation of STAT5 and STAT3FEBS Letters, 1995